Hip Osteoarthritis

Hip osteoarthritis is a degenerative joint disease characterized by progressive loss of articular cartilage, subchondral bone remodeling, and osteophyte formation in the hip joint, leading to pain, stiffness, and impaired mobility.

2. Epidemiology

3. Risk Factors

4. Anatomy and Function of the Hip Joint

Understanding the anatomy is essential for understanding why hip OA presents the way it does and why certain surgical approaches carry specific risks.

5. Etiology (Focus on Hong Kong)

6. Pathophysiology

Understanding the pathophysiology of OA is fundamental. The lecture slides provide an excellent diagram of the molecular biology [3].

7. Classification

8. Clinical Features

Differential Diagnosis of Hip Pain

The first learning outcome of the hip arthritis lecture is to formulate differential diagnosis for patients with hip pain [1]. This is critical because "hip pain" is a symptom, not a diagnosis — and many conditions masquerade as hip OA. Your job is to systematically work through the possibilities, guided by the patient's age, pain location, onset, and associated features.

Systematic Differential Diagnosis by Category

References

[1] Lecture slides: GC 229. Hip Arthritis (1).pdf (pp. 2, 32, 81, 103) [2] Senior notes: maxim.md (section 6.3 OA hip) [5] Senior notes: maxim.md (section 6.4 AVN of hip) [6] Lecture slides: GC 229. Hip Arthritis (1).pdf (p. 53 — Imaging for septic arthritis) [7] Senior notes: maxim.md (section 6.2 Hip trauma — fracture neck of femur) [8] Senior notes: maxim.md (sections on SCFE, Perthes disease) [9] Senior notes: felixlai.md (section on differential diagnosis of intermittent claudication — sciatica) [10] Lecture slides: GC 226. Lumbar Spine Pathology_Part E (2).pdf (p. 2) [11] Senior notes: maxim.md (section 1.2 History taking — differential diagnosis tiers)

Diagnostic Criteria, Diagnostic Algorithm & Investigations for Hip Osteoarthritis

1. Diagnostic Criteria — How Do We Actually Diagnose Hip OA?

Unlike many medical conditions, hip OA does not have a single pathognomonic lab test. The diagnosis is fundamentally clinical + radiological. Let's work through this from first principles.

3. Investigation Modalities — Detailed Breakdown

3.1 Plain Radiographs (X-rays) — The First-Line Investigation

Plain X-ray is the cornerstone investigation for hip OA [1][12]. It is cheap, widely available, and provides the key diagnostic information.

3.2 MRI — The Gold Standard for Soft Tissue and Early Disease

MRI is not routinely needed for diagnosing established hip OA (X-ray is sufficient). It is indicated when:

  1. X-ray is normal but clinical suspicion is high (pre-radiographic OA, occult fracture, early AVN)
  2. Suspected AVNMRI has 99% sensitivity and specificity [14] for AVN
  3. Suspected labral tear or FAI — MR arthrogram (with intra-articular gadolinium) is the investigation of choice
  4. Distinguishing osteomyelitis from septic arthritisMRI may be the most useful test to distinguish proximal femoral osteomyelitis from septic arthritis of the hip [6]
  5. Suspected occult fracture — stress fracture or insufficiency fracture with normal X-ray

References

[1] Lecture slides: GC 229. Hip Arthritis (1).pdf (pp. 2, 29, 32) [2] Senior notes: maxim.md (sections 6.3 OA hip, 9.1 Osteoarthritis) [3] Lecture slides: GC 228. Knee Osteoarthritis_Part B (1).pdf (p. 13 — Natural History of OA) [5] Senior notes: maxim.md (section 6.4 AVN of hip) [6] Lecture slides: GC 229. Hip Arthritis (1).pdf (p. 53 — Imaging for septic arthritis) [7] Senior notes: maxim.md (section 7.4 OA knee — Kellgren-Lawrence classification) [12] Lecture slides: GC 229. Hip Arthritis (1).pdf (p. 103 — Take Home Messages) [13] Lecture slides: GC 228. Knee Osteoarthritis_Part A (1).pdf (p. 32 — Radiographic features) [14] Lecture slides: GC 229. Hip Arthritis (1).pdf (pp. 15, 20 — AVN investigations and Ficat classification) [15] Lecture slides: GC 229. Hip Arthritis (1).pdf (p. 51 — Investigations for septic arthritis) [16] Senior notes: maxim.md (section 6.3 — Harris Hip Score after THR)

Management of Hip Osteoarthritis

3. First-Line Treatment — Non-Pharmacological Core Treatment (ALL Patients)

This is the foundation of OA management. It should be offered to every single patient, regardless of disease severity.

4. Second-Line Treatment — Pharmacological and Adjunctive (SOME Patients)

Added when core treatments alone do not achieve adequate symptom control.

5. Third-Line Treatment — Surgery (FEW Patients)

Indications for operative management [2]:

  • Patient factors: age, functional status, comorbidities, expectations
  • Disease factors: severe impairment to ADL, pain despite conservative treatment

The key question is: joint-preserving surgery vs. joint replacement?

5.1 Joint-Preserving Surgery

5.2 Joint Replacement — The Definitive Treatment for End-Stage Hip OA

Total hip replacement is a reliable and durable treatment option for patients with end stage arthritis [12].

References

[1] Lecture slides: GC 229. Hip Arthritis (1).pdf (p. 81 — Management of DDH) [2] Senior notes: maxim.md (sections 6.3 OA hip, 9.1 Osteoarthritis — Management) [7] Senior notes: maxim.md (sections 6.2 Hip trauma, 7.4 OA knee — KL classification, surgical options) [11] Senior notes: maxim.md (section 1.3 Management overview — ERAS, walking aids) [12] Lecture slides: GC 229. Hip Arthritis (1).pdf (p. 103 — Take Home Messages) [14] Lecture slides: GC 229. Hip Arthritis (1).pdf (p. 20 — Ficat classification and treatment) [17] Lecture slides: GC 228. Knee Osteoarthritis_Part A (1).pdf (pp. 35–36 — OA Treatment Pyramid) [18] Lecture slides: GC 228. Knee Osteoarthritis_Part B (1).pdf (p. 30 — First-line management question) [19] Lecture slides: GC 228. Knee Osteoarthritis_Part A (1).pdf (p. 42 — COME programme) [20] Lecture slides: GC 228. Knee Osteoarthritis_Part B (1).pdf (p. 29 — Conclusion) [21] Lecture slides: GC 229. Hip Arthritis (1).pdf (pp. 37–38 — Physiotherapy evidence) [22] Lecture slides: GC 229. Hip Arthritis (1).pdf (p. 39 — Analgesics) [23] Lecture slides: GC 228. Knee Osteoarthritis_Part B (1).pdf (p. 8 — Paracetamol evidence) [24] Lecture slides: GC 228. Knee Osteoarthritis_Part B (1).pdf (p. 10 — Opioids) [25] Lecture slides: GC 229. Hip Arthritis (1).pdf (p. 44 — Intra-articular hyaluronic acid) [26] Lecture slides: GC 229. Hip Arthritis (1).pdf (p. 34 — AAOS guideline reference) [27] Senior notes: maxim.md (section 9.1 — Osteotomy vs Arthroplasty table) [28] Lecture slides: GC 228. Knee Osteoarthritis_Part B (1).pdf (p. 18 — Limited role of arthroscopy) [29] Lecture slides: GC 229. Hip Arthritis (1).pdf (p. 64 — Management goals for THR) [30] Lecture slides: GC 229. Hip Arthritis (1).pdf (p. 92 — Multidisciplinary approach for AS)

Complications of Hip Osteoarthritis

Complications of hip OA fall into two broad categories: (A) complications of the disease itself (untreated or progressive OA), and (B) complications of treatment (particularly surgical). Both are high-yield for exams. Let's work through each systematically, explaining the "why" from first principles.


Part A: Complications of the Disease Itself

Part B: Complications of Treatment

B2. Complications of Total Hip Replacement (THR)

These are extremely high-yield and explicitly listed in the senior notes [2][33]:

Specific complications of THR: thromboembolism, dislocation, infection of prosthesis, leg length discrepancy [2]

The senior notes provide a temporal classification [33]:

References

[2] Senior notes: maxim.md (section 6.3 OA hip — specific complications) [5] Senior notes: maxim.md (section 6.4 AVN of hip — bisphosphonates and ONJ) [7] Senior notes: maxim.md (section 6.2 Hip trauma — dislocation prevention post-THR) [11] Senior notes: maxim.md (section 1.3 Management overview — ERAS protocol) [12] Lecture slides: GC 229. Hip Arthritis (1).pdf (p. 103 — Take Home Messages) [16] Senior notes: maxim.md (section 6.3 — Harris Hip Score) [22] Lecture slides: GC 229. Hip Arthritis (1).pdf (p. 39 — Analgesics) [23] Lecture slides: GC 228. Knee Osteoarthritis_Part B (1).pdf (p. 8 — Paracetamol) [24] Lecture slides: GC 228. Knee Osteoarthritis_Part B (1).pdf (p. 10 — Opioids) [28] Lecture slides: GC 228. Knee Osteoarthritis_Part B (1).pdf (p. 18 — Arthroscopy complications) [31] Lecture slides: GC 228. Knee Osteoarthritis_Part A (1).pdf (p. 5 — OA is a serious disease) [32] Lecture slides: GC 229. Hip Arthritis (1).pdf (p. 55 — Late complications) [33] Senior notes: maxim.md (section 9.1 — Specific complications of total replacement)

High Yield Summary

  1. Hip OA = joint failure — involves cartilage, subchondral bone, synovium, capsule, and periarticular muscles.
  2. Primary hip OA is uncommon in the Chinese population — always think secondary causes in Hong Kong.
  3. Secondary causes to know: DDH, AVN (steroids > 20 mg/day, alcohol, trauma, SLE, caisson disease, sickle cell), infection (old TB hip), inflammatory arthritis (RA), crystal deposition (gout), neuropathic (Charcot), metabolic/endocrine.
  4. AVN risk factors: Trauma (femoral neck fracture 15–50%, hip dislocation 10–25%), alcohol, steroids, caisson disease, sickle cell.
  5. Radiological features (LOSS): Loss of joint space (earliest), Osteophytes, Subchondral sclerosis, Subchondral cysts.
  6. Key symptoms: Deep groin pain aggravated by weight-bearing, morning stiffness < 30 min, stiffness (difficulty with shoes/socks), loss of function (walking, stairs, public transport).
  7. Key signs: Externally rotated limb at rest, antalgic gait, Trendelenburg gait (end-stage), painful limited ROM (IR lost first), fixed flexion deformity (Thomas test +), muscle wasting.
  8. Internal rotation is the first movement lost — because the capsule is tightest in IR.
  9. Hip pain can be referred to the knee (Hilton's Law; obturator nerve L2–L4) — always examine the hip when a patient presents with knee pain.
  10. DDH management: Periacetabular osteotomy if congruent joint space preserved and no OA; THR if secondary OA established.
  11. Natural history: Molecular → Pre-radiographic (MRI) → Radiographic (X-ray) → End-stage (joint replacement). Intervene early for best outcomes.
  12. Harris Hip Score evaluates pain, function (walking, stairs, shoes/socks, sitting, public transport), deformity, and ROM.
  13. OA vs RA: OA = weight-bearing joints, preserved bone density, osteophytes, no erosions. RA = any joint, juxta-articular osteopenia, erosions, no reactive bony changes.

High Yield Summary — DDx of Hip Pain

  1. Pain location is the single most useful discriminator: Groin = intra-articular; Lateral = periarticular (GTPS); Buttock/radiating below knee = referred (spine).
  2. Hip OA DDx from senior notes: fractures, sciatica, trochanteric bursitis, gluteus medius tendinopathy.
  3. Age guides the differential: Child (Perthes, DDH, septic arthritis, SCFE) → Young adult (AVN, DDH, FAI, labral tear, AS) → Elderly (primary OA, fracture, metastasis, spinal stenosis).
  4. Passive ROM is the key sign: Restricted = intra-articular. Full = periarticular or referred.
  5. AVN is a major secondary cause in HK — risk factors: steroids > 20 mg/day, alcohol, trauma (NOF 15–50%, dislocation 10–25%), caisson disease, sickle cell.
  6. Septic arthritis is the emergency "don't miss" — acute, febrile, very painful, restricted ROM; aspirate urgently. MRI distinguishes osteomyelitis from septic arthritis.
  7. TB hip is historically significant in Hong Kong — chronic destruction, X-ray shows capsular distension, joint space widening, then destruction.
  8. Always examine the lumbar spine when assessing hip pain — referred pain from the spine is extremely common.
  9. On X-ray, describe features by location (acetabular side, articular surface, femoral side) and look for clues to secondary causes (DDH: dysplasia; AVN: crescent sign; AS: SI fusion; TB: Phemister triad).

High Yield Summary — Diagnosis of Hip OA

  1. Diagnosis is clinical + radiological — no specific lab test for OA.
  2. ACR criteria: Hip pain + 2 of 3 (ESR < 20, osteophytes on X-ray, joint space narrowing).
  3. First-line investigation: Plain X-ray (AP pelvis + lateral of affected hip).
  4. Radiographic hallmarks (LOSS): Loss of joint space (earliest), Osteophytes (most reliable), Subchondral sclerosis, Subchondral cysts.
  5. Describe X-ray by location: acetabular side, articular surface, femoral side.
  6. Kellgren-Lawrence grading: Grade 0 (normal) to Grade 4 (bone-on-bone).
  7. Always look for secondary causes on X-ray: DDH (dysplasia), AVN (crescent sign), AS (SI fusion), TB (capsular distension), RA (erosions/osteopenia).
  8. MRI: 99% sensitive/specific for AVN (double-line sign); best for pre-radiographic OA, labral tears, and distinguishing osteomyelitis from septic arthritis.
  9. Bloods are to exclude differentials, not to diagnose OA: ESR, CRP, WCC (infection); RF, anti-CCP (RA); urate (gout); HLA-B27 (AS).
  10. Image-guided aspiration: urgent for suspected septic arthritis — cell count, Gram smear, bacterial/fungal/AFB culture, +/- crystals.
  11. Ficat classification for AVN: I (normal X-ray) → core decompression; II (sclerotic/cystic) → core decompression/bone graft; III (subchondral collapse) → bone graft/THR; IV (OA changes) → THR.
  12. Harris Hip Score: Pain (44) + Function (47) + ROM + Deformity = max 100. Used for baseline and post-THR follow-up.
  13. Natural history: Molecular → Pre-radiographic (MRI/biomarkers) → Radiographic (X-ray) → End-stage. Intervene early.

High Yield Summary — Management of Hip OA

  1. First-line = Education, Exercise, Weight Control (ALL patients) — NOT analgesics, NOT surgery.
  2. OA Treatment Pyramid: Core non-pharmacological (all) → Pharmacological + adjuncts (some) → Surgery (few).
  3. Physiotherapy — Strong evidence for improving function and reducing pain in mild-moderate hip OA.
  4. Analgesics do NOT affect natural history — symptomatic relief only.
  5. Paracetamol = first-line analgesic but network meta-analysis shows no demonstrable benefit in OA at any dose; used for safety profile relative to NSAIDs.
  6. NSAIDs have proven benefit but GI, renal, and cardiovascular side effects limit their use.
  7. Tramadol: non-narcotic, synergistic with paracetamol, use if NSAIDs contraindicated.
  8. Opioids: NO routine use — limited benefit, serious adverse effects (addiction, falls in elderly, worse surgical outcomes).
  9. Intra-articular hyaluronic acid: Strong evidence AGAINST — does not outperform placebo for hip OA.
  10. Intra-articular steroid: short-term relief, image-guided, useful as bridge.
  11. Surgical indications: severe ADL impairment + pain despite conservative treatment.
  12. Joint-preserving: Osteotomy (young < 60, preserved cartilage), PAO (DDH before OA), Core decompression (AVN Ficat I–II).
  13. THR = reliable and durable for end-stage arthritis. Surgical approaches relative to gluteus medius: Posterior (most common, preserves abductors but risk of dislocation/sciatic nerve injury), Anterolateral/Hardinge (good exposure but superior gluteal nerve injury), Anterior/Smith-Petersen (rare, for infected hip washout).
  14. THR goals: restore pain-free stable joint, restore anatomical hip centre (acetabular), correct femoral deformity, address soft tissue contractures, protect sciatic nerve.
  15. Harris Hip Score for pre- and post-operative assessment.
  16. Multidisciplinary approach for inflammatory causes (rheumatologist + orthopaedic surgeon).

High Yield Summary — Complications of Hip OA and THR

  1. OA is a serious disease: increased risk of cardiovascular/respiratory disorder, psychological disorder, sleep disturbance, and mortality.
  2. Disease complications: progressive disability, fixed flexion/ER/adduction deformity, Trendelenburg gait, secondary OA of adjacent joints, falls.
  3. Late complications of hip pathology (from lecture slides): secondary OA, stiffness/ankylosis/contracture, deformity (angulation, coxa vara, shortening), instability/dislocation, leg length discrepancy.
  4. The Big Four THR complications: thromboembolism (DVT/PE), dislocation, prosthesis infection, leg length discrepancy.
  5. Nerve injury by approach: Posterior → sciatic nerve; Anterolateral → superior gluteal nerve.
  6. Dislocation prevention: no squatting, no crossing legs, no hip flexion > 90°, abduction pillow, high-low chair.
  7. Aseptic loosening is the most common reason for revision THR — caused by wear particle-induced osteolysis.
  8. PJI is the most devastating complication — biofilm formation makes eradication difficult; often requires two-stage revision.
  9. Prosthesis survival: 15–20 years without revision.
  10. Opioid complications in OA: limited benefit, addiction, falls in elderly, worse surgical outcomes — NOT recommended routinely.
  11. Arthroscopy in OA: very limited role; increases rate of OA progression and shortens time to joint replacement.

On this page

No Headings